2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea
Diabetes & Metabolism Journal
;
: 398-406, 2019.
Article
Dans Anglais
| WPRIM
| ID: wpr-763670
ABSTRACT
The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the 6th Clinical Practice Guidelines in 2019. Targets of glycemic, blood pressure, and lipid control in type 2 diabetes mellitus (T2DM) were updated. The obese and overweight population is increasing steadily in Korea, and half of the Koreans with diabetes are obese. Evidence-based recommendations for weight-loss therapy for obesity management as treatment for hyperglycemia in T2DM were provided. In addition, evidence from large clinical studies assessing cardiovascular outcomes following the use of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM were incorporated into the recommendations.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Pression sanguine
/
Diabète de type 2
/
Diagnostic
/
Surpoids
/
Glucagon-like peptide 1
/
Hyperglycémie
/
Corée
/
Obésité
Type d'étude:
Etude diagnostique
/
Guide de pratique
Limites du sujet:
Humains
Pays comme sujet:
Asie
langue:
Anglais
Texte intégral:
Diabetes & Metabolism Journal
Année:
2019
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS